医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

PENTAX Europe GmbH Appoints Rainer Burkard President of Europe, Middle East and Africa Region (EMEA)

2015年08月03日 PM05:25
このエントリーをはてなブックマークに追加


 

HAMBURG, Germany

PENTAX Europe GmbH, a division of HOYA Corporation, announced the appointment of Mr. Rainer Burkard to the position of President Europe, Middle East and Africa (EMEA) as of 1st August 2015. In this executive role, Rainer Burkard is responsible for leading all PENTAX Medical activities in the EMEA region.

“Rainer joins PENTAX Medical with valuable expertise gained from various segments of the healthcare industry”, said Hiroshi Suzuki, CEO and President of HOYA Group. “He has the credentials and business leadership to oversee PENTAX Medical’s operations throughout Europe, the Middle East and Africa, and will build upon our strategy and infrastructure to strengthen our position as a leading endoscopy solutions provider in EMEA.”

Rainer Burkard joined the HOYA Group in 2002 and since that time he has held several senior positions across the areas of Business Development, Management and Marketing. Most recently, he served as Executive Director of SEIKO Optical.

“This role offers a great opportunity to take PENTAX Medical forward in the EMEA region”, Rainer Burkard says. “I am committed to ensuring we clearly will demonstrate the PENTAX Medical ethos of offering the most clinically advanced products, supported by excellent customer service to clinicians across EMEA.”

About PENTAX Medical

PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. For more information, please visit: www.pentaxmedical.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150803005520/en/

CONTACT

PENTAX Europe GmbH
Katharina Meitzler, +49-40-56192-0
Project
Manager Marketing Communications
katharina.meitzler@pentaxmedical.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • AGICキャピタルがATECファーマテクニックの過半数持ち分を取得
  • Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia
  • 辉凌基于微生物群的首创活体生物治疗药物REBYOTA®(粪便微生物群,live-jslm)获得美国FDA批准
  • Bio-Thera Solutions Announces Presentation of BAT8009 (B7-H3-ADC) at the 2nd Annual ADC Target Selection Summit
  • Bio-Thera Solutions Announces BAT8006 (Folate-Receptor-α-ADC) and BAT8008 (Trop2-ADC) Poster Presentations at the 2022 San Antonio Breast Cancer Symposium